UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities and Exchange Act of 1934
Date of report (Date of earliest event reported):
April 27, 2006
EASTMAN CHEMICAL COMPANY
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 1-12626 | 62-1539359 | ||
(State or Other Jurisdiction of | (Commission File Number) | (IRS Employer Identification No.) | ||
Incorporation) |
200 South Wilcox Drive, Kingsport, TN | 37660 | |
(Address of Principal Executive Offices) | (Zip Code) |
(423) 229-2000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
EASTMAN CHEMICAL COMPANY - EMN | April 27, 2006 |
Item 2.02 Results of Operations and Financial Condition
On April 27, 2006, the registrant publicly released its financial results for first quarter 2006. The full text of the release is furnished as Exhibit 99.01 to this Form 8-K, and is incorporated herein by reference. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
This Form 8-K includes the following non-GAAP financial measures:
Eastman Chemical Company Operating Earnings, Earnings Before Income Taxes, Net Earnings and Net Earnings Per Diluted Share excluding: asset impairments and restructuring charges, other operating income, and net deferred tax benefit related to sales of certain businesses, product lines, and assets in the CASPI segment.
Eastman’s management believes that the asset impairments and restructuring charges, net deferred tax benefit, and other operating income do not reflect ongoing business results. However, management believes that these items are indicative of the performance of certain businesses and product lines, results of continuous efforts to reduce costs, and results of other actions to improve the profitability of the company. Management believes that investors can better evaluate and analyze historical and future business trends if they also consider the reported results without the identified items. Management utilizes corporate earnings and operating results excluding the identified items in the measures it uses to evaluate corporate and segment performance and in determining certain performance-based compensation. These measures are not recognized in accordance with generally accepted accounting principles (GAAP) and should not be viewed as alternatives to the GAAP measures of performance. Table 5 in the accompanying first-quarter 2006 financial tables reconciles operating earnings, earnings before income taxes, net earnings and net earnings per diluted share on a GAAP basis, as reflected in Eastman’s Consolidated Statements of Earnings, to operating earnings, earnings before income taxes, net earnings and net earnings per diluted share excluding asset impairments and restructuring charges, other operating income, and net deferred tax benefit.
EASTMAN CHEMICAL COMPANY - EMN | April 27, 2006 |
Item 9.01 Financial Statements and Exhibits:
(c) Exhibits
The following exhibit is furnished pursuant to Item 9.01:
99.01 Public release by the registrant on April 27, 2006 of first quarter 2006 financial results.
EASTMAN CHEMICAL COMPANY - EMN | April 27, 2006 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Eastman Chemical Company | ||
By: /s/ Curtis E. Espeland Curtis E. Espeland Vice President and Chief Accounting Officer | ||
Date: April 27, 2006 |